Archive

  • NHS funding will be major headwind for UK longevity assumptions

    07 October 2022

    On the positive side, Hymans Robertson expert points to a potential anti-ageing drug

Cookies on InsuranceERM

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here